5429-07-2 Usage
Uses
Since the exact applications, stability, and safety profile of 2-[(7-Chloro-4-quinolinyl)sulfanyl]acetic acid have not been commonly reported in open literature, the following potential uses are speculative and based on the general properties of similar compounds:
Used in Pharmaceutical Industry:
2-[(7-Chloro-4-quinolinyl)sulfanyl]acetic acid could be used as an active pharmaceutical ingredient for the development of new drugs, given its unique chemical structure and potential interactions with biological targets.
Used in Chemical Research:
In the field of chemical research, 2-[(7-Chloro-4-quinolinyl)sulfanyl]acetic acid may serve as a starting material or intermediate in the synthesis of more complex molecules, contributing to the advancement of organic chemistry.
Used in Industrial Applications:
Depending on its physical and chemical properties, 2-[(7-Chloro-4-quinolinyl)sulfanyl]acetic acid might be employed in various industrial processes, such as in the production of specialty chemicals, dyes, or materials with specific properties.
Check Digit Verification of cas no
The CAS Registry Mumber 5429-07-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,2 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5429-07:
(6*5)+(5*4)+(4*2)+(3*9)+(2*0)+(1*7)=92
92 % 10 = 2
So 5429-07-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H8ClNO2S/c12-7-1-2-8-9(5-7)13-4-3-10(8)16-6-11(14)15/h1-5H,6H2,(H,14,15)
5429-07-2Relevant articles and documents
Synthesis and antimalarial activity of (S)-methyl-(7-chloroquinolin-4-ylthio)acetamidoalquilate derivatives
Colmenarez, Custodiana,Acosta, María,Rodríguez, Miguel,Charris, Jaime
, p. 161 - 166 (2020/01/09)
The synthesis of five new (S)-methyl-(7-chloroquinolin-4-ylthio)acetamidoalquilate derivatives is carried out under a modified version of the Steglich esterification reaction between different l-amino acid methyl esters and 2-(7-chloroquinolin-4-ylthio)acetic acid. Two of the compounds showed significant inhibition (>50%) of β-hematin formation. The two active structures were tested in vivo as potential antimalarials in mice infected with Plasmodium berghei ANKA, a chloroquine susceptible strain. Compounds 6b and 6e exhibited antimalarial activity comparable to that of chloroquine.
